Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E50.4 - Economics and Challenges of Pathway Design
Description: Patient empowerment can be an overlooked, yet critical success factor for putting a dent in Fatty Liver disease. In this conversation, the panelists investigate the economics of pathway design while identifying challenges and opportunities for effective solutions.The preceding dialogue has suggested that the guideline processes are too focused on opportunities for private sector product developers to make money. Roger Green challenges this idea by identifying FIB-4 as the first stage test across all guidelines and pathways. He notes FIB-4 is an inexpensive test that will not profit manufacturers. Louise Campbell agrees before shifting focus to challenges...